Mimicking coronavirus could be key for a COVID-19 vaccine

A specialist works at Binnopharm pharmaceutical plant, part of Alium Group owned by Sistema financial corporation, which develops "Gam-COVID-Vac" vaccine against the coronavirus disease (COVID-19) in Zelenograd near Moscow, Russia September 18, 2020. REUTERS/Maxim Shemetov - RC201J9XEXFT

Hundreds of vaccines against COVID-19 are being developed across the world. Image: REUTERS/Maxim Shemetov

Barbara Branning
Content writer, Buffalo University
Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:


Have you read?
COVID-19 Vaccination Pandemic Preparedness and Response
The vaccine partially mimics the structure of the virus. Image: Advanced Materials
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19VaccinationPandemic Preparedness and Response
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

From smallpox to COVID: the medical inventions that have seen off infectious diseases over the past century

Andrea Willige

May 11, 2023

About Us



Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum